5VM
5AM Venture Management Portfolio holdings
AUM
$260M
This Quarter Return
+1.95%
1 Year Return
+3.76%
3 Year Return
+144.87%
5 Year Return
+32.61%
10 Year Return
–
AUM
$555M
AUM Growth
+$555M
(+87%)
Cap. Flow
+$280M
Cap. Flow
% of AUM
50.47%
Top 10 Holdings %
Top 10 Hldgs %
99.43%
Holding
11
New
1
Increased
–
Reduced
2
Closed
–
Top Buys
| 1 |
Vor Biopharma
VOR
|
$288M |
Top Sells
| 1 |
Cabaletta Bio
CABA
|
$4.3M |
| 2 |
Aprea Therapeutics
APRE
|
$3.87M |
Sector Composition
| 1 | Healthcare | 99.34% |
| 2 | Financials | 0.66% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Vor Biopharma
VOR
$250M
| $288M | 51.94% | +6,692,429 | New | +$288M |
|
|
AKUS
2
DELISTED
Akouos, Inc. Common Stock
AKUS
| $57.4M | 10.33% | 4,135,784 | – | – |
|
3
Q32 Bio
QTTB
$20.9M
| $42.7M | 7.69% | 4,535,919 | – | – |
|
4
IDEAYA Biosciences
IDYA
$2.15B
| $42.3M | 7.61% | 1,798,066 | – | – |
|
|
5
Cabaletta Bio
CABA
$133M
| $33.1M | 5.96% | 2,984,263 -387,000 | -11% | -$4.3M |
|
6
Arvinas
ARVN
$568M
| $33.1M | 5.95% | 500,000 | – | – |
|
7
scPharmaceuticals
SCPH
$295M
| $25.5M | 4.59% | 3,831,474 | – | – |
|
8
Crinetics Pharmaceuticals
CRNX
$2.92B
| $20.8M | 3.75% | 1,362,286 | – | – |
|
9
Cidara Therapeutics
CDTX
$1.66B
| $5.34M | 0.96% | 2,006,511 | – | – |
|
|
FVAM
10
DELISTED
5:01 Acquisition Corp. Class A Common Stock
FVAM
| $3.65M | 0.66% | 365,126 | – | – |
|
|
11
Aprea Therapeutics
APRE
$9.09M
| $3.16M | 0.57% | 619,157 -758,497 | -55% | -$3.87M |
|